samedan logo
 
 
 
spacer
home > ebr > autumn 2020 > medical communications transformed
PUBLICATIONS
European Biopharmaceutical Review

Medical Communications Transformed

Like other business sectors, medical health communications or ‘medhealth comms’ has been completely upended by the COVID-19 pandemic. This £13 billion industry has had to adapt to a new reality, and fast, in order to meet the rapidly changing needs of its stakeholders. First let’s take a step back and explain the importance of medhealth comms.

Explaining Medhealth Comms

Simply put, medhealth comms help pharmaceutical developers to better communicate with their stakeholders, including healthcare practitioners, such as doctors, nurses, prescribers, and, of course, patients. A drug company launching a new product will have reams of highly-technical data and reports that are hard to understand. Medhealth comms can help turn these complex data into clear, credible, and effective communications. Alternatively, a national regulator like the National Institute for Health and Care Excellence, which is responsible for providing national guidance and advice to improve health and social care, might publish new guidelines on COVID-19 or a specific treatment. Medhealth comms will help interpret them so healthcare professionals (HCPs) can better understand them. Accurate information and honest opinions help HCPs to make treatment decisions with confidence, leading to better patient outcomes.

Traditionally, this has been done in a variety of ways, by creating impactful collaterals such as interactive publication tools, case studies, educational videos, logos, and branding. It’s also done by organising seminars and conferences that bring together HCPs, drug companies, and third-party independent experts.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Following a successful career in the pharma industry, Shairose Ebrahim founded imc in 2006 from her home office. The company has gone from strength to strength and today employs over 100 staff across five divisions, with five offices in London, Cambridge, Toronto, Boston, and Cairo, working with some of the world’s biggest pharma companies to deliver better outcomes for patients. Shairose credits healthcare heroes who inspired her to succeed in her career, including Dr Jane Cooke Wright who developed a non-surgical method of fighting tumours, Dr Mae Jemison who was appointed by NASA to conduct experiments in space, and Dr Patricia Bath who created an entirely new discipline of ophthalmology focused on public health.
spacer
Shairose Ebrahim
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility to Increase Biologics Manufacturing Capabilities in Europe

SOMERSET, N.J. – July 21, 2021 – Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it will commence the first phase of a planned $100 million expansion program at its facility in Anagni, Italy, to add biologics drug substance manufacturing capabilities, supporting the growing European market demand for biologics manufacture and supply.
More info >>

White Papers

Wrap Around Label - A Lot of Content in a Small Space

Faubel & Co. Nachfolger GmbH

One of the world’s largest contract research organizations for the planning and conducting of clinical trials was faced with the challenge of accommodating many different national languages on an inhaler. The inhaler was then to be distributed in 47 countries. Due to the impressive quality and reliable collaboration, the organization commissioned Faubel with finding the optimal labeling solution for the inhaler.
More info >>

 
Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement